Chronic Obstructive Pulmonary Disease I: Introduction

COPD results from long-term exposure to harmful particles or gases causing chronic inflammation and lung damage. Major risk factors include tobacco smoke, occupational dust and chemical fumes, indoor air pollution from biomass fuels, and infections like tuberculosis or repeated childhood pneumonia. Genetic factors, particularly alpha-1 antitrypsin deficiency, also increase susceptibility to early-onset COPD.

Chronic inflammation causes lasting structural changes in airways and air sacs. These changes include emphysema, which destroys alveolar walls and reduces elastic recoil, and chronic bronchitis, characterized by airway inflammation and excess mucus production. Together, these pathological processes limit airflow and impair gas exchange.

Emphysema involves destruction of alveolar walls and loss of elastic recoil in air sacs. Chronic bronchitis is defined by chronic cough and sputum production due to airway inflammation and mucus hypersecretion. Although distinct in origin, these conditions often coexist in COPD patients and together contribute to airflow limitation.

Alpha-1 antitrypsin is a protective enzyme that counteracts proteolytic enzymes in the lungs. Deficiency of this protein impairs the lungs' ability to defend against tissue-damaging enzymes, leading to accelerated lung damage and increased risk of early-onset emphysema even with minimal environmental exposure.

Long-term occupational exposure to dust such as silica and cotton, and chemical fumes, damages lung tissue over time. Indoor air pollution from biomass fuels in poorly ventilated homes and urban air pollution also increase COPD risk. These exposures accumulate gradually, leading to progressive lung damage and airflow limitation.

Early-life factors including recurrent respiratory infections, poor lung development from prematurity, and childhood asthma increase susceptibility to COPD later in life. These conditions may compromise initial lung development and function, making individuals more vulnerable to subsequent environmental exposures and chronic inflammation.

Yes, COPD is preventable and treatable. It is a common lung disorder characterized by persistent respiratory symptoms and airflow limitation. Prevention focuses on avoiding harmful exposures like tobacco smoke and occupational hazards, while treatment aims to manage symptoms and slow disease progression.